📰 Overactive Bladder News
Page 168 - Overactive Bladder News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Overactive Bladder. Real-time updates on events, politics, business and more.
April 15, 2022
Physiotherapy Course - Internal Vaginal Physiotherapy Examination Practical Course - Australia - New South Wales (Sydney) - 2567 - Narellan
April 12, 2022
/PRNewswire/ -- BlueWind Medical, Ltd., developer of the innovative RENOVA iStim™ implantable tibial neuromodulation (iTNM) device for treatment of Overactive...
February 4, 2022
Bayer will no longer work on eliapixant, an Evotec-partnered asset that was studied across four indications in midstage tests, including chronic cough. The companies will continue working together on other assets in phase 1, preclinical and discovery stages.
February 1, 2022
According to the latest research by Future Market Insights, Bowel Stimulators market is set to witness a 6.3% growth during the year 2021-2031. The market has been developing at a gradual rate and is projected to witness lucrative growth due to increasing number of population suffering from Overactive Bladder (OAB)...
January 28, 2022
/PRNewswire/ -- The "Market Spotlight: Overactive Bladder" report has been added to ResearchAndMarkets.coms offering. Overactive bladder is characterized by...
January 28, 2022
/PRNewswire/ -- The "Market Spotlight: Overactive Bladder" report has been added to ResearchAndMarkets.coms offering. Overactive bladder is characterized by...
January 10, 2022
A table of risk factors for overactive bladder and urinary incontinence in men and women.
January 8, 2022
/PRNewswire/ -- BlueWind Medical™, Ltd., developer of the innovative RENOVA™ iStim implantable neuromodulation device for treatment of Overactive Bladder,...
January 6, 2022
/PRNewswire/ -- BlueWind Medical™, Ltd., developer of the innovative RENOVA™ iStim implantable neuromodulation device for treatment of Overactive Bladder,...
January 6, 2022
PARK CITY, Utah and HERZLIYA, Israel, Jan. 6, 2022 /PRNewswire/ -- BlueWind Medical™, Ltd., developer of the innovative RENOVA™ iStim implantable neuromodulation device for treatment of Overactive Bladder, today announced